Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I Study to Evaluate the Safety and Pharmacokinetics of CB-5339 in Participants with Relapsed/Refractory Acute Myeloid Leukemia or Intermediate-High Risk Myelodysplastic Syndrome
Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
A Phase II Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway?Mutant Acute Lymphoblastic Leukemia
Study Type: Treatment
Phase: II
NCTID: NCT02723994
Principal Investigator:
Kevin Ginn
A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan GMI-1271 in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Study Type: Treatment
Phase: II
NCTID: NCT03834961
Principal Investigator:
Keith August
A Phase 1 Study of ASP2215 in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
A Phase III, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome?Positive Acute Lymphoblastic Leukemia Ph+ ALL
A Pilot Study of Targeted Daunorubicin Dosing to Overcome Chemotherapeutic Resistance in Children with Relapsed or Refractory Acute Leukemia
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT04562792
Principal Investigator:
Chandni Dargan